PPT-Digoxin And Mortality in Patients With Atrial Fibrillation
Author : ellena-manuel | Published Date : 2017-08-16
Renato D Lopes MD PhD FACC on behalf of the ARISTOTLE Investigators Disclosures The ARISTOTLE trial was sponsored by BristolMyers Squibb and Pfizer The present
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Digoxin And Mortality in Patients With A..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Digoxin And Mortality in Patients With Atrial Fibrillation: Transcript
Renato D Lopes MD PhD FACC on behalf of the ARISTOTLE Investigators Disclosures The ARISTOTLE trial was sponsored by BristolMyers Squibb and Pfizer The present analysis was sponsored by . The LAA is a normal part of the heart anatomy and causes no problems in the general population However this pouch is a major source of blood clots in patients with atrial fibrillation Atrial fibrillation AF is the biggest risk factor for blood clots fibrillation: diagnosis and management. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. A U G U S T 2 0 1 4. Physicians. 2. Physicians. A majority of physicians believe most Atrial Fibrillation patients don’t usually understand their increased risk of stroke and feel most patients underestimate the impact ischemic stroke can have on their lives. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . Wessex. A report for Wessex AHSN ‘Atrial Fibrillation: Detect, Perfect, Protect’ . Programme. Dr . Anastasios. Argyropoulos. Centre for Implementation Science. A.Argyropoulos@soton.ac.uk . Wessex. Freedom . from atrial fibrillation at 12 . months: 63. % of the mitral valve surgery plus ablation group . vs. . 29% of the mitral valve surgery alone group (p < . 0.001). Among . the ablation group, freedom from atrial fibrillation occurred in 61% with PVI vs. 66% with . Pharmacology of digoxin. Clinical Uses. Overview. Introduction. Toxicity and management. 1. 2. 3. 4. Digitalis: Cardiac glycoside that occurs naturally in plants. Its medical use dates back from the 18. ischaemic. attack in patients with. a diagnosis of resolved atrial fibrillation: . retrospective cohort. . studies.. Nicola J Adderley, . Krishnarajah. . Nirantharakumar. , Tom Marshall.. BMJ 2018.
Download Document
Here is the link to download the presentation.
"Digoxin And Mortality in Patients With Atrial Fibrillation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents